Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glucagon-Like Peptide-1 Receptor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06608433
What this trial is testing

Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function

Who this might be right for
Healthy Volunteer StudyHPACortisol Deficiency+1 more
University Hospital, Basel, Switzerland 22
Not applicableStudy completedNCT01767389
What this trial is testing

Glucagon-like Peptide (GLP) Utilization and Safety

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 1
Large-scale testing (Phase 3)Study completedNCT06739044
What this trial is testing

Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 494
Large-scale testing (Phase 3)Looking for participantsNCT07082114
What this trial is testing

Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 800
Not applicableNot Yet RecruitingNCT06764056
What this trial is testing

Characterization and Management of Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

Who this might be right for
Metabolic Associated Fatty Liver DiseaseMetabolic Associated-dysfunction Steatohepatitis (MASH)Obesity
Institut universitaire de cardiologie et de pneumologie de Québec, University Laval 120
Testing effectiveness (Phase 2)Study completedNCT05895643
What this trial is testing

Does Semaglutide Reduce Alcohol Intake in Patients With Alcohol Use Disorder and Comorbid Obesity?

Who this might be right for
Alcohol AbuseAlcohol AddictionAlcohol Dependence+1 more
Psychiatric Centre Rigshospitalet 108
Not applicableEnrolling By InvitationNCT06924697
What this trial is testing

Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2Nicotine Dependence, Cigarettes
Shanghai East Hospital 46
Not applicableNot Yet RecruitingNCT07784127
What this trial is testing

Whole Gut Motility Abnormalities Following GLP-1 Receptor Agonist (GLP-1RA) Initiation

Who this might be right for
Diabetes
The Cleveland Clinic 20
Not applicableStudy completedNCT07096739
What this trial is testing

Tolerance of a High Protein Nutrition Shake in Individuals on GLP-1

Who this might be right for
GLP-1 Concentration
Kate Farms Inc 20
Large-scale testing (Phase 3)Study completedNCT04466566
What this trial is testing

Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics

Who this might be right for
Healthy
Adrian Vella 21
Not applicableLooking for participantsNCT07309094
What this trial is testing

Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

Who this might be right for
Chronic Kidney Disease stage3Chronic Kidney Disease stage4Chronic Kidney Disease Stage 1+3 more
Cardenal Herrera University 250
Not applicableLooking for participantsNCT07213323
What this trial is testing

Probiotic Intervention for Digestive Health in Obese Patients Initiating GLP-RA Treatment

Who this might be right for
Obesity &Amp; OverweightDigestive Disorders
Hospices Civils de Lyon 50
Not applicableStudy completedNCT03010683
What this trial is testing

Effects of Agonists of Glucagon Like Peptide - 1 Receptors (GLP-1R) on Arterial Stiffness, Endothelial Glycocalyx and Coronary Flow Reserve in Patients With Coronary Artery Disease and Patients With Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusCoronary Artery Disease
University of Athens 60
Testing effectiveness (Phase 2)Looking for participantsNCT06518837
What this trial is testing

Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast Cancer

Who this might be right for
Hormone Receptor-Positive Breast CancerHER2-Negative Breast Cancer
Rutgers, The State University of New Jersey 40
Not applicableLooking for participantsNCT07803185
What this trial is testing

Evaluation of Anhedonia and Emotional Eating in Individuals Using GLP-1 Receptor Agonists

Who this might be right for
ObesityEmotional EatingAnhedonia
TC Erciyes University 60
Post-approval studies (Phase 4)Looking for participantsNCT07242534
What this trial is testing

Effect of Semaglutide on Embryo Quality in Overweight and Obese Patients Undergoing In Vitro Fertilization.

Who this might be right for
InfertilityObesity
Fundacion Dexeus 62
Not applicableStudy completedNCT07269821
What this trial is testing

Evaluation of a Nutritional Intervention With Dietary Supplements in People Who Have Recently Lost Weight: Effects on Body Composition, Emotional Health, and Gut Microbiota

Who this might be right for
GLP-1Weight Loss TrajectoryEmotional Disorder+1 more
University of Alicante 70
Post-approval studies (Phase 4)Looking for participantsNCT07588438
What this trial is testing

Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay.

Who this might be right for
ObesityDiabetes Mellitus, Type 2
Las Rías Medical Center 160
Large-scale testing (Phase 3)Looking for participantsNCT07428746
What this trial is testing

Investigating the Impact of GLP-1 RA Therapy on Osteosarcopenia in Older Female Adults With Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Emory University 20
Not applicableLooking for participantsNCT06725693
What this trial is testing

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

Who this might be right for
GLP1-R-related DiseaseTumorInsulinoma+1 more
Tianjin Medical University 500
Next Page